IC
GILD icon

Intersect Capital’s Gilead Sciences GILD Stock Holding History

Intersect Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$514K Buy
8,315
+137
+2% +$8.48K 0.16% 146
2022
Q1 		$486K Sell
8,178
-1,482
-15% -$94.7K 0.09% 201
2021
Q4 		$701K Buy
9,660
+6,151
+175% +$424K 0.13% 142
2021
Q3 		$245K Buy
3,509
+606
+21% +$42.6K 0.04% 322
2021
Q2 		$200K Buy
+2,903
New +$194K 0.04% 355
2020
Q4 		– Sell
-4,329
Closed -$274K – 294
2020
Q3 		$274K Sell
4,329
-1,239
-22% -$85.9K 0.07% 178
2020
Q2 		$428K Buy
5,568
+1,260
+29% +$96.6K 0.14% 106
2020
Q1 		$322K Buy
+4,308
New +$298K 0.13% 121
2019
Q3 		– Sell
-4,097
Closed -$277K – 170
2019
Q2 		$277K Sell
4,097
-74
-2% -$4.87K 0.11% 140
2019
Q1 		$271K Sell
4,171
-198
-5% -$13.2K 0.11% 112
2018
Q4 		$273K Sell
4,369
-468
-10% -$32.7K 0.13% 102
2018
Q3 		$373K Buy
4,837
+2
+0% +$151 0.16% 91
2018
Q2 		$342K Buy
4,835
+4
+0.1% +$282 0.16% 92
2018
Q1 		$364K Sell
4,831
-1,266
-21% -$101K 0.19% 85
2017
Q4 		$437K Buy
6,097
+1,621
+36% +$123K 0.24% 79
2017
Q3 		$363K Sell
4,476
-8
-0.2% -$612 0.21% 82
2017
Q2 		$317K Buy
4,484
+270
+6% +$18K 0.19% 85
2017
Q1 		$286K Sell
4,214
-711
-14% -$50K 0.25% 73
2016
Q4 		$353K Buy
4,925
+915
+23% +$68K 0.26% 72
2016
Q3 		$317K Sell
4,010
-1,789
-31% -$145K 0.25% 78
2016
Q2 		$484K Sell
5,799
-28
-0.5% -$2.48K 0.29% 65
2016
Q1 		$535K Buy
5,827
+1,240
+27% +$112K 0.34% 59
2015
Q4 		$464K Buy
4,587
+274
+6% +$28.5K 0.4% 58
2015
Q3 		$424K Sell
4,313
-775
-15% -$86.1K 0.39% 59
2015
Q2 		$596K Buy
5,088
+150
+3% +$16.4K 0.51% 49
2015
Q1 		$496K Buy
4,938
+1,345
+37% +$137K 0.38% 54
2014
Q4 		$339K Buy
+3,593
New +$372K 0.28% 61

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Intersect Capital's GILD Position: Q2 2022 in Review

Intersect Capital increased its Gilead Sciences (GILD) stake by 1.7% in Q2 2022, buying an estimated $8.48K and bringing the position to 8,315 shares worth $514K. The position accounts for 0.16% of the portfolio, ranked #146.

Intersect Capital first reported a position in GILD in Q4 2014 and has held it in 27 quarters since. The position peaked at $701K in Q4 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Intersect Capital held 8,315 shares of Gilead Sciences worth $514K as of Q2 2022.
  • Intersect Capital bought 137 Gilead Sciences shares in Q2 2022, an estimated $8.48K.
  • Gilead Sciences made up 0.16% of Intersect Capital's portfolio in Q2 2022, its #146 holding.
  • Intersect Capital first reported a position in Gilead Sciences in Q4 2014 and has held it in 27 quarters since.
  • Intersect Capital's Gilead Sciences position peaked at $701K in Q4 2021.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.